ited in our technical abilities to control bleeding. When bleeding occurs, vision is usually severely hampered, further limiting our coagulation ability. Would these factors negatively impact the safety level of NEB procedures? Establishing the correct pathological diagnosis based on the tiny specimens harvested through an NEB can be challenging. Tissue retrieved from the tumor periphery, a sampling error, and an occasional inability to see the pathological structure are all potential sources for histopathological inaccuracies. In the large cohort in this study, we had the opportunity to compare the pathology obtained from an NEB with the "gold-standard" pathology obtained during open surgery. Would the NEB results provide a lower level of diagnostic accuracy?
Retrospective data were collected from 13 randomly chosen medical centers that routinely performed NEBs between January 1998 and December 2009. Each center had completed a minimum of 15-20 endoscopic biopsies. While individual centers may have contributed very small numbers of NEB patients to the current study, all participating centers had expressed a strong academic and clinical interest in neuroendoscopy and were routinely performing a wide range of endoscopic procedures in addition to the NEBs.
Each medical center had its own criteria for performing the procedure. Patient data had to include detailed pathological information. All information collected was entered into a database (FileMaker Pro 6, FileMaker, Inc.). We used SPSS software (SPSS Institute, Inc.) to analyze data and check for any statistical correlations between demographic, anatomical, or technical variables, and morbidity, feasibility, or biopsy accuracy. Both Pearson and complete range of variables, including universal complications, bleeding, pathology, mismatch between biopsy -nique and equipment, tumor size, number of samples, and use of navigational aids.
We analyzed data for 293 patients from 13 centers (Table 1) . Patients had a mean age of 28.3 22.2 years (range 0.1-78.7 years), and 60% were male.
Upon presentation, 196 patients (67%) had elevated intracranial pressure. Tumor anatomy spanned a wide range of locations and sizes ( Table 2 ). The most common tumor locations were pineal (33.1%), thalamic (16.7%), tectal (13%), and hypothalamic (4.4%). Fifty percent of the tumors were larger than 20 mm, 36% were between 10 and 20 mm, and 14% were smaller than 10 mm.
Approach side, number of bur holes, and type of scope were among the technical variables documented (Table  3) . Navigation devices were used 15.4% of the time, and continuous rinsing was used in 47% of the procedures. The average number of specimens per procedure was 4.2.
Note that we collected and analyzed a wide range of surgical parameters, including universal complications, bleeding, pathology, mismatch between biopsy results and -nique, type of equipment (biopsy forceps and endoscope), tumor size, number of samples, and use of navigational aids. However, most of the factors analyzed were found to results. For example, we found that the use of navigation had no effect on the complication rate or diagnostic yield, and neither did surgical technique, choice of implements, use of irrigation, and any other variable examined. These the study results.
Complications during and after NEB are summarized in Table 4 . The amount of intraoperative bleeding was noted as mild in 75%, moderate in 13%, and severe in 6%. Infection occurred in 8 patients (3%). One patient (0.3%) died because of severe intraoperative bleeding. Four cases of CSF leakage were reported with no infection. Table 5 . Biopsies were informative in 90.4% of the patients. Results included low-grade astrocytoma (21.5%), high-grade astrocytoma (12.6%), germ cell tumor (12.3%), juvenile pilocytic astrocytoma (10%), other (8.5%), and unknown (9.6%).
Intraoperative frozen sections were analyzed in 34% of the patients (100 patients). The frozen sections were proven accurate in 57.6%, questionable in 17.2%, and noninterpretable in 25.2%.
Seventy-eight patients (27%) had open surgery following the NEB. The reason for subsequent open surgery after NEB was attributable to oncological considerations, in most cases following resolution of hydrocephalus. All 78 patients had completed NEB procedures that provided meaningful pathological results.
We compared the pathology results from the NEBs with those from the subsequent open surgeries (Table 6 ). meaningful) mismatch, in which the erroneous NEB pathology would not have altered the management decision, -match, in which the erroneous NEB pathology could have led to an inappropriate management decision, occurred in 9 cases (11.5%). Six (43%) of the 14 mismatches, which included both meaningful and nonmeaningful instances, were actually found to be low-grade astrocytomas. Three (21%) of the other mismatches were actually found to be juvenile pilocytic astrocytomas. In no instance was a tumor mistaken for a high-grade tumor after the NEB, reevaluated, and changed to a low-grade category. This is the largest available multicenter study evaluating the safety and accuracy of NEBs for brain tumor. Previous information on this subject has been reported smaller numbers of patients. [2] [3] [4] [5] 12, 15, 16, 19 The large number of patients included in our cohort, spanning a wide range of ages and pathologies, allowed us to examine many variables relevant to the NEB's clinical implications. The large number of participating centers enabled us to identify factors that are common across different surgeons and different departments, and therefore may be more Thus, this study effectively demonstrates the advantages of shared data and international multicenter studies.
Based on information in this cohort, NEBs are relatively safe. We report a fairly low and mostly reversible complication rate of < 13% (in 293 procedures), with almost no long-term morbidity and only a single death due to severe intraoperative bleeding. (Apparently, during -dure abortion and the need for a ventricular drain, with gradual deterioration of the patient's condition within 2 days to a state of brain death.) Despite these encouraging numbers, one must remember that all of our data came from experienced centers. It is important to keep in mind that, in general, NEBs are advanced procedures requiring a learning curve and the appropriate technology.
Neuroendoscopic biopsies provided meaningful pathological data for over 90% of the patients, for a wide range of tumor types, locations, and presentations. This number is comparable with the pathological validity of SNBs. [6] [7] [8] 10, 13, 14, 18 The SNB diagnostic yield is heavily dependent on the patient population studied. For example, SNBs of smaller lesions with deeper locations offer lower accuracy compared with SNBs of larger, peripherally based tumors. This is why SNB diagnostic yields have been found to range from 62% to 100%. 6, 8, 18 Parreño et al. 13 reported usable diagnostic specimens in 100% of pediatric patients, whereas Jackson et al. 7 noted a very low diagnostic yield of 62% with SNBs of tumors located in or near eloquent brain areas. The overall diagnostic yield and safety of NEB and SNB seem to be comparable, with the reliability of NEB results, as demonstrated by the current study, less dependent on tumor location.
There are many advantages to NEB as compared with SNB. Neuroendoscopic biopsies are the preferred technique for tumors with an epicenter within the ventricular walls. Such lesions may be more hazardous to "blind" biopsy with stereotaxy, as the needle may not be surrounded by tissue and the anatomy may change upon -biopsy, and provide an opportunity to examine the biopsy site and verify that there is no active bleeding. In addition, this type of biopsy procedure can easily be extended to include additional procedures such as relieving CSF pressure through endoscopic third ventriculostomy and septum pellucidotomy. 1,2,9,17 As such, we conclude that for lesions whose epicenter lies within a ventricle or those with concomitant hydrocephalus, NEB is to be preferred Pathology was inconsistent to some degree in 14 cases (17.9%). However, it is important to distinguish between inconsistencies that did not make any difference in terms which the erroneous NEB pathology could have led to an inappropriate treatment decision. pathological mismatches that could have led to a mistaken clinical decision. In most cases, the mismatches occurred in tumor cases that appeared to be low grade but were actually a higher grade, as seen in the open procedure pathology. (Note that the shift from low-to high-grade pathology remained within the same histopathological family, meaning, for example, that a low-grade glial tumor was reclassiThis pattern of low-grade/high-grade mismatches is certainly an important factor when making treatment decisions following an NEB that reveals a low-grade pathology. In such cases, it must be acknowledged that about 1 in 5 such patients may, in fact, harbor a higher-grade pathology.
With this understanding, it is clear that at the end of the day NEB provided a valid working diagnosis approximately 90% of the time. This reliability rate is essentially comparable to the rate seen with stereotactic biopsies, which suffer from a similar vulnerability to sampling error and have a similar risk of higher-grade tumors appearing to be lower grade. The overall diagnostic yield and safety of NEB and SNB seem to be comparable, with the reliability of NEB results less dependent on tumor location.
Neuroendoscopic biopsies can be performed with low morbidity and mortality, providing meaningful pathological data for the majority of patients with a wide range of tumor types, locations, and presentations. Neuroendoscopic biopsies also offer other advantages, such as the ability to perform concomitant endoscopic third ventriculostomy and septum pellucidotomy. Note, however, that pathological results obtained from NEBs can be misleading, especially those that seem to indicate a low-grade glial tumor. 
